NEW YORK, May 25, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Chinese Pharmaceutical Regulatory Report 2011
http://www.reportlinker.com/p0510897/Chinese-Pharmaceutical-Regulatory-Report-2011.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
This report includes a brief overview of the pharmaceutical and healthcare industry in China, as well as a discussion of all the relevant laws and regulations that govern the testing, registration, manufacture, import, marketing, and sale of pharmaceutical products. Specific topics include: product registration, pricing and reimbursement, importation, GMP, GCP, orphan drugs, and intellectual property protection. The appendix contains a full translation of the revised Administrative Provisions for Drug Registration, the recent overhaul of China's drug regulations. It also contains the annexes to this document detailing dossier submission requirements, all up-to-date.
To order this report:
Drug and Medication Industry: Chinese Pharmaceutical Regulatory Report 2011
Drug and Medication Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Contact
Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
Chinese Pharmaceutical Regulatory Report 2011
http://www.reportlinker.com/p0510897/Chinese-Pharmaceutical-Regulatory-Report-2011.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication
Advertisement
This report includes a brief overview of the pharmaceutical and healthcare industry in China, as well as a discussion of all the relevant laws and regulations that govern the testing, registration, manufacture, import, marketing, and sale of pharmaceutical products. Specific topics include: product registration, pricing and reimbursement, importation, GMP, GCP, orphan drugs, and intellectual property protection. The appendix contains a full translation of the revised Administrative Provisions for Drug Registration, the recent overhaul of China's drug regulations. It also contains the annexes to this document detailing dossier submission requirements, all up-to-date.
To order this report:
Drug and Medication Industry: Chinese Pharmaceutical Regulatory Report 2011
Drug and Medication Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Contact
Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
